シンバイオ製薬(株)企業情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4582/E24682 | - |
日証金(2024-04-18付)
- 信用売り残高
- 0株
- 前日比
- 0%
- 信用買い残高
- 10万9500株
- 前日比
- -2.23%
もっと見る
東証(2024-04-12付)
- 信用売り残高
- 0株
- 前週比
- -100%
- 信用買い残高
- 346万7700株
- 前週比
- -0.88%
もっと見る
日々公表信用残(2021-12-02付)
- 信用売り残高
- 1万3800株
- 前日比
- 411.11%
- 信用買い残高
- 527万3000株
- 前日比
- -0.69%
もっと見る
日証協(2024-04-12付)
- 貸付残高
- 840万7449株
- 前週比
- 2.91%
- 貸付新規
- 40万6371株
- 前週比
- -31.13%
もっと見る
機関の空売り残高情報
計算日 | 空売り者 | 残高割合 | 増減率 | 残高数量 | 増減量 | 備考 |
---|
2021/02/09 | UBS AG | 0.960% | 0% | 369,225株 | | 再IN(前回2020-11-11) |
2020/11/11 | UBS AG | 0.410% | -0.090% | 150,725株 | -27,700 | 報告義務消失 |
2020/11/10 | UBS AG | 0.500% | 0% | 178,425株 | | 再IN(前回2020-10-26) |
2020/10/26 | UBS AG | 0.480% | -0.020% | 170,425株 | -5,900 | 報告義務消失 |
2020/10/23 | UBS AG | 0.500% | -0.190% | 176,325株 | -69,000 | |
2020/10/16 | UBS AG | 0.690% | -0.010% | 245,325株 | -3,200 | |
2020/10/07 | UBS AG | 0.700% | +0.100% | 248,525株 | +36,600 | |
2020/10/05 | UBS AG | 0.600% | +0.020% | 211,925株 | +7,000 | |
2020/10/02 | UBS AG | 0.580% | 0% | 204,925株 | | 再IN(前回2020-06-05) |
2020/06/05 | UBS AG | 0.460% | -0.070% | 163,525株 | -25,400 | 報告義務消失 |
2020/06/03 | UBS AG | 0.530% | -0.150% | 188,925株 | -45,100 | |
2020/05/29 | UBS AG | 0.680% | -0.070% | 234,025株 | -21,600 | |
2020/05/27 | UBS AG | 0.750% | -0.080% | 255,625株 | -28,000 | |
2020/05/20 | UBS AG | 0.830% | 0% | 283,625株 | | 再IN(前回2020-05-12) |
2020/05/12 | UBS AG | 0.450% | -0.100% | 156,125株 | -33,100 | 報告義務消失 |
2020/05/11 | UBS AG | 0.550% | -0.170% | 189,225株 | -48,700 | |
2020/05/08 | UBS AG | 0.720% | -0.130% | 237,925株 | -37,300 | |
2020/05/07 | UBS AG | 0.850% | -0.080% | 275,225株 | -17,700 | |
2020/05/01 | UBS AG | 0.930% | +0.110% | 292,925株 | +34,000 | |
2020/04/30 | UBS AG | 0.820% | 0% | 258,925株 | | 再IN(前回2019-10-23) |
2019/10/23 | UBS AG | 0.430% | -0.140% | 106,100株 | -33,900 | 報告義務消失 |
2019/10/17 | UBS AG | 0.570% | -0.080% | 140,000株 | -18,600 | |
2019/10/15 | UBS AG | 0.650% | -0.130% | 158,600株 | -33,000 | |
2019/10/04 | UBS AG | 0.780% | -0.020% | 191,600株 | -4,800 | |
2019/10/01 | UBS AG | 0.800% | +0.200% | 196,400株 | +47,900 | |
2019/09/26 | UBS AG | 0.600% | +0.060% | 148,500株 | +16,700 | |
2019/09/19 | UBS AG | 0.540% | 0% | 131,800株 | | 再IN(前回2018-11-21) |
2018/11/21 | UBS AG | 0.450% | -0.200% | 360,600株 | -158,500 | 報告義務消失 |
2018/11/20 | UBS AG | 0.650% | -0.040% | 519,100株 | -20,000 | |
2018/11/19 | UBS AG | 0.690% | -0.330% | 539,100株 | -255,600 | |
2018/11/16 | UBS AG | 1.020% | -0.070% | 794,700株 | -57,400 | |
2018/10/23 | UBS AG | 1.090% | -0.010% | 852,100株 | -8,900 | |
2018/10/18 | UBS AG | 1.100% | -0.030% | 861,000株 | -20,300 | |
2018/10/15 | UBS AG | 1.130% | +0.060% | 881,300株 | +43,000 | |
2018/10/12 | UBS AG | 1.070% | +0.010% | 838,300株 | +12,600 | |
2018/10/11 | UBS AG | 1.060% | +0.050% | 825,700株 | +34,800 | |
2018/10/10 | UBS AG | 1.010% | +0.040% | 790,900株 | +34,800 | |
2018/10/09 | UBS AG | 0.970% | +0.020% | 756,100株 | +11,700 | |
2018/10/02 | UBS AG | 0.950% | +0.210% | 744,400株 | +161,000 | |
2018/10/01 | UBS AG | 0.740% | -0.020% | 583,400株 | +200 | |
2018/09/28 | UBS AG | 0.760% | +0.080% | 583,200株 | +60,400 | |
2018/09/27 | UBS AG | 0.680% | 0% | 522,800株 | | 再IN(前回2018-09-26) |
2018/09/26 | UBS AG | 0.490% | -0.010% | 375,800株 | -3,500 | 報告義務消失 |
2018/09/25 | UBS AG | 0.500% | -0.050% | 379,300株 | -35,600 | |
2018/09/21 | UBS AG | 0.550% | -0.010% | 414,900株 | -6,500 | |
2018/09/20 | UBS AG | 0.560% | +0.010% | 421,400株 | +4,800 | |
2018/09/14 | UBS AG | 0.550% | -0.010% | 416,600株 | -6,200 | |
2018/09/12 | UBS AG | 0.560% | +0.020% | 422,800株 | +19,500 | |
2018/09/11 | UBS AG | 0.540% | +0.010% | 403,300株 | +500 | |
2018/09/10 | UBS AG | 0.530% | -0.030% | 402,800株 | -19,400 | |
2018/09/06 | UBS AG | 0.560% | -0.040% | 422,200株 | -19,400 | |
2018/09/04 | UBS AG | 0.600% | +0.040% | 441,600株 | +37,400 | |
2018/08/31 | UBS AG | 0.560% | -0.030% | 404,200株 | -18,300 | |
2018/08/30 | UBS AG | 0.590% | 0% | 422,500株 | | |
Page Top